Cell and Gene Therapy CRO Market- By Type of Cell Therapy
Cell and Gene Therapy CRO Market- By Type of Genetic Modification
Cell and Gene Therapy CRO Market-By Stage of Development
Cell and Gene Therapy CRO Market-By Therapeutic Area
Cell and Gene Therapy CRO Market-By End-Users
Cell and Gene Therapy CRO Market-By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy CRO Market Snapshot
Chapter 4. Global Cell and Gene Therapy CRO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Cell Therapy Estimates & Trend Analysis
5.1. by Type of Cell Therapy & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Cell Therapy:
5.2.1. CAR-NK
5.2.2. CAR-T
5.2.3. TCR-T
5.2.4. Others
Chapter 6. Market Segmentation 2: by Type of Genetic Modification Estimates & Trend Analysis
6.1. by Type of Genetic Modification& Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Genetic Modification:
6.2.1. Ex vivo
6.2.2. In vivo
Chapter 7. Market Segmentation 3: by Stage of Development Estimates & Trend Analysis
7.1. by Stage of Development & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Stage of Development:
7.2.1. Discovery
7.2.2. Preclinical
7.2.3. Clinical
Chapter 8. Market Segmentation 4: by Therapeutic Area Estimates & Trend Analysis
8.1. by Therapeutic Area & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Area:
8.2.1. Blood Disorders
8.2.2. Cardiovascular Disorders
8.2.3. Dermatological Disorders
8.2.4. Immunological Disorders
8.2.5. Infectious Diseases
8.2.6. Metabolic Disorders
8.2.7. Musculoskeletal Disorders
8.2.8. Neurological Disorders
8.2.9. Oncological Disorders
8.2.10. Rare Diseases
8.2.11. Other disorders
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
9.2.1. Industry Players
9.2.2. Non-Industry Players
Chapter 10. Cell and Gene Therapy CRO Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.1.2. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification,2019-2031
10.1.3. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.1.4. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.1.5. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.2.2. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification ,2019-2031
10.2.3. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.2.4. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2019-2031
10.2.5. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.3.2. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification,2019-2031
10.3.3. Asia-Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.3.4. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2019-2031
10.3.5. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.4.2. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification, 2019-2031
10.4.3. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.4.4. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.4.5. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.5.2. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification, 2019-2031
10.5.3. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development, 2019-2031
10.5.4. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.5.5. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Altasciences
11.2.2. Allucent
11.2.3. CMIC
11.2.4. Labcorp
11.2.5. Linical
11.2.6. Medpace
11.2.7. PPD
11.2.8. Precision for Medicine
11.2.9. QPS
11.2.10. Syneos Health
11.2.11. CMED
11.2.12. ICON
11.2.13. Pharmalex
11.2.14. Novotech
11.2.15. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.